Search for: "Merck Sharp & Dohme Ltd"
Results 41 - 60
of 61
Sort by Relevance
|
Sort by Date
28 May 2013, 5:05 am
Merck Sharp & Dohme Corp., No. [read post]
6 Sep 2012, 8:08 am
Merck Sharp & Dohme Corp v Apotex Pty Ltd [2012] FCA 928 (31 August 2012) Interlocutory injunctions – prima facie case – balance of convenience – permanent impact of generic competition upon market for pharmaceutical products The Federal Court of Australia (Justice Jagot) has issued a preliminary injunction barring generic pharmaceutical manufacturer from marketing and selling nasal sprays containing the corticosteroid mometasone furoate… [read post]
19 Mar 2012, 5:42 am
Court of Appeal (Criminal Division) R. v SVS Solicitors [2012] EWCA Crim 319 (15 February 2012) A v B & Anor [2012] EWCA Civ 285 (14 March 2012) Court of Appeal (Civil Division) Maqsood v Mahmood & Anor [2012] EWCA Civ 251 (13 March 2012) JD (Congo) & Ors v Secretary of State for the Home Department [2012] EWCA Civ 327 (16 March 2012) Barr & Ors v Biffa Waste Services Ltd [2012] EWCA Civ 312 (19 March 2012) High Court (Queen’s Bench Division) Travelers… [read post]
3 Aug 2011, 3:31 am
General EU – India agreement in WTO dispute raises bar for EU drug seizures (IP Watch) EU: CJEU rules on repackaging of pharma goods: Joined Cases C-400/09 and C-207/10 Orifarm and Paranova v Merck Sharp Dohme (Class 46) (IPKat) EU: Ophtal v Oftal Cusi- General Court upholds finding of no likelihood of confusion for identical goods in T-160/09 (Class 46) EU: The holiday is over: a close reading of the opinion in Medeva: Joined Cases C? [read post]
11 Apr 2011, 2:45 am
Court of Appeal (Civil Division) Merck Sharp & Dohme Corp v Teva UK Ltd [2011] EWCA Civ 382 (08 April 2011) High Court (Queen’s Bench Division) Williams v Central Bank of Nigeria [2011] EWHC 876 (QB) (08 April 2011) The Legal Services Commission v F & Ors [2011] EWHC 899 (QB) (08 April 2011) High Court (Chancery Division) Moria & Anor v Bednash [2011] EWHC 839 (Ch) (08 April 2011) Batt v Royal Mail [2011] EWHC 900 (Ch) (08 April 2011) High… [read post]
10 Apr 2011, 1:43 am
In my article "Divided by a common language: US and UK patent law" which was published in Science, People & Politics (April to June 2011) I noted that one of the differences between US and UK patent law was that 35 USC 102 (b) of the US act permits an application for a US patent even where the invention has been described in a publication or application for a foreign patent that has been made in [read post]
9 Apr 2011, 9:07 am
The IPKat has had his attention directed to the decision in Merck Sharp & Dohme Corp v Teva UK Ltd, [2011] EWCA Civ 382, a ruling of the Court of Appeal for England and Wales (Sir Andrew Morrit, The Chancellor of the High Court, providing a judgment with which Richards and Patten LJJ agreed) handed down yesterday.To summarise: Teva had applied for revocation of Merck’s European Patent (EP(UK) 0509752), relating to “ophthalmic compositions… [read post]
12 Jan 2011, 5:45 pm
., Flex-Time Lawyers, Merck Sharp & Dohme Corp., National Corporate Research, Ltd., and The Vanguard Group Learn more at New Partner and In-House Counsel Conference. [read post]
30 Jun 2010, 5:52 am
Ltd. et al v. [read post]
29 Jun 2010, 6:01 pm
Ltd. et al v. [read post]
28 Jun 2010, 3:08 am
Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
27 Jun 2010, 6:00 pm
Paranova Danmark A/S, Paranova Pack A/S v Merck Sharp & Dohme Corp. [read post]
16 Jun 2010, 3:02 pm
(Patent Docs) Cubicin (Daptomycin) – US: Cubist Pharmaceuticals to oppose Teva’s attempt to add inequitable conduct defense in patent infringement action (SmartBrief) Dorzolamide/Timolol – Netherlands: Preliminary injunction judge rules UK invalidity decision not sufficient to rule non-negligible chance that (Dutch part of) patent will be invalidated in proceedings on the merits: Merck Sharp & Dohme v. [read post]
18 Mar 2010, 2:30 am
(Patent Docs) Atripla (Emtricitabine) - US: District Court S D New York: Patent infringement suit filed following a Paragraph IV Certification: Merck, Sharp & Dohme Corp. et al. v. [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott Laboratories et al… [read post]
24 Feb 2010, 2:11 am
Co. v Doll (Filewrapper) US: District Court Massachusetts denies bid for bench trial in RNAi patent suit: Max-Planck-Gesellschaft v Whitehead Institute for Biomedical Research (Patent Docs) US: Court of Appeal for the Ninth Circuit: Federal jurisdiction found in Neuralstem v Reneuron (Patent Docs) US: District Court New Jersey: Disqualification of counsel in patent case requires ‘factual analysis’, not ‘automatic disqualification rule’: Wyeth et al v Abbott Laboratories et al… [read post]
17 Feb 2010, 5:10 am
Merck, Sharp & Dohme Corp. [read post]
5 Aug 2009, 7:59 am
EPO - Get your house in order - understand how applications have changed over the last 12 months, and how your company needs to adapt to gain first time patent approval 2009 confirmed speakers include: Bo Hammer Janssen, Senior Patent Counsel, Novozymes Nicolas Ruiz, Head of IP, Esteve Dr Mandar Kodgule, Head, Intellectual Property and Strategic Planning, Wockhardt Ltd Dr William Heggie, CSO, Hovione James Horgan, Assistant Counsel, Merck, Sharpe &… [read post]
17 Dec 2008, 11:40 am
Court of Appeal (Civil Division) MA v Merck Sharp & DOHME Ltd [2008] EWCA Civ 1426 (16 December 2008) Animatrix Ltd & Ors v O’Kelly [2008] EWCA Civ 1415 (16 December 2008) Calvert v William Hill Credit Ltd [2008] EWCA Civ 1427 (16 December 2008) Allan v Johnson Controls Automative (UK) Ltd [2008] EWCA Civ 1377 (16 December 2008) Smith [...] [read post]
24 Aug 2008, 10:16 am
Current members of the TMPDF are ARM Ltd; AstraZeneca plc; Babcock International Ltd; BAE Systems plc; BP p.l.c.; British Telecommunications plc; British-American Tobacco Co Ltd; BTG plc; Delphi Corp.; Dow Corning Ltd; Dyson Technology Ltd; ExxonMobil Chemical Ltd; Ford of Europe; Fujitsu Services Ltd; G E Healthcare; GKN plc; GlaxoSmithKline plc; Hewlett-Packard Ltd; IBM UK Ltd; Infineum UK Ltd; Kodak… [read post]
